Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5Z5R

Nukacin ISK-1 in inactive state

Summary for 5Z5R
Entry DOI10.2210/pdb5z5r/pdb
NMR InformationBMRB: 36158
DescriptorLantibiotic nukacin (1 entity in total)
Functional Keywordslantibiotics, antibiotic
Biological sourceStaphylococcus warneri
Total number of polymer chains1
Total formula weight2970.53
Authors
Kohda, D.,Fujinami, D. (deposition date: 2018-01-19, release date: 2018-11-28, Last modification date: 2024-07-10)
Primary citationFujinami, D.,Mahin, A.A.,Elsayed, K.M.,Islam, M.R.,Nagao, J.I.,Roy, U.,Momin, S.,Zendo, T.,Kohda, D.,Sonomoto, K.
The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states.
Commun Biol, 1:150-150, 2018
Cited by
PubMed Abstract: The lantibiotic nukacin ISK-1 exerts antimicrobial activity through binding to lipid II. Here, we perform NMR analyses of the structure of nukacin ISK-1 and the interaction with lipid II. Unexpectedly, nukacin ISK-1 exists in two structural states in aqueous solution, with an interconversion rate on a time scale of seconds. The two structures differ in the relative orientations of the two lanthionine rings, ring A and ring C. Chemical shift perturbation induced by the titration of lipid II reveals that only one state was capable of binding to lipid II. On the molecular surface of the active state, a multiple hydrogen-bonding site formed by amino acid residues in the ring A region is adjacent to a hydrophobic surface formed by residues in the ring C region, and we propose that these sites interact with the pyrophosphate moiety and the isoprene chain of the lipid II molecule, respectively.
PubMed: 30272026
DOI: 10.1038/s42003-018-0150-3
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon